JP2024532438A5 - - Google Patents
Info
- Publication number
- JP2024532438A5 JP2024532438A5 JP2024513446A JP2024513446A JP2024532438A5 JP 2024532438 A5 JP2024532438 A5 JP 2024532438A5 JP 2024513446 A JP2024513446 A JP 2024513446A JP 2024513446 A JP2024513446 A JP 2024513446A JP 2024532438 A5 JP2024532438 A5 JP 2024532438A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- composition according
- protofibril antibody
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163260730P | 2021-08-30 | 2021-08-30 | |
| US63/260,730 | 2021-08-30 | ||
| US202263306050P | 2022-02-02 | 2022-02-02 | |
| US63/306,050 | 2022-02-02 | ||
| US202263269389P | 2022-03-15 | 2022-03-15 | |
| US63/269,389 | 2022-03-15 | ||
| US202263269463P | 2022-03-16 | 2022-03-16 | |
| US63/269,463 | 2022-03-16 | ||
| US202263364619P | 2022-05-12 | 2022-05-12 | |
| US63/364,619 | 2022-05-12 | ||
| PCT/US2022/041926 WO2023034230A1 (en) | 2021-08-30 | 2022-08-29 | Subcutaneous formulations of anti-abeta protofibril antibody and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532438A JP2024532438A (ja) | 2024-09-05 |
| JP2024532438A5 true JP2024532438A5 (https=) | 2025-09-05 |
Family
ID=83438517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513446A Pending JP2024532438A (ja) | 2021-08-30 | 2022-08-29 | 抗Ａβプロトフィブリル抗体の皮下製剤及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240352109A1 (https=) |
| EP (1) | EP4395821A1 (https=) |
| JP (1) | JP2024532438A (https=) |
| KR (1) | KR20240053620A (https=) |
| AU (1) | AU2022338055A1 (https=) |
| CA (1) | CA3230148A1 (https=) |
| MX (1) | MX2024002567A (https=) |
| TW (1) | TW202328178A (https=) |
| WO (1) | WO2023034230A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260022396A (ko) * | 2023-06-09 | 2026-02-19 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 항-Aβ 프로토피브릴 항체를 사용한 치료 방법 |
| CN116953261B (zh) * | 2023-08-10 | 2024-09-17 | 浙江格物致知生物科技有限公司 | 一种检测脓毒症的联检试剂盒及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2414772C (en) | 2000-07-07 | 2011-06-28 | Jan Naslund | Prevention and treatment of alzheimer's disease |
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| RU2429244C2 (ru) | 2006-03-23 | 2011-09-20 | Байоарктик Ньюросайенс Аб | Улучшенные селективные в отношении протофибрилл антитела и их применение |
| LT2448968T (lt) | 2009-06-29 | 2021-05-10 | Bioarctic Ab | Antikūnai, atpažįstantys n gale sutrumpintas amiloido protofibriles/oligomerus |
| JP5894939B2 (ja) | 2010-02-26 | 2016-03-30 | バイオアークティック ニューロサイエンス アーベー | プロトフィブリル結合抗体ならびにパーキンソン病、レビー小体型認知症および他のα−シヌクレイノパチーの治療および診断方法におけるこれらの使用 |
| WO2016005466A2 (en) | 2014-07-10 | 2016-01-14 | Bioarctic Neuroscience Ab | IMPROVED Aß PROTOFIBRIL BINDING ANTIBODIES |
| BR112019008359A2 (pt) * | 2016-10-27 | 2019-10-01 | Eisai R&D Man Co Ltd | método para tratamento da doença de alzheimer, e, composição farmacêutica. |
-
2022
- 2022-08-29 US US18/688,264 patent/US20240352109A1/en active Pending
- 2022-08-29 JP JP2024513446A patent/JP2024532438A/ja active Pending
- 2022-08-29 WO PCT/US2022/041926 patent/WO2023034230A1/en not_active Ceased
- 2022-08-29 KR KR1020247010680A patent/KR20240053620A/ko active Pending
- 2022-08-29 CA CA3230148A patent/CA3230148A1/en active Pending
- 2022-08-29 AU AU2022338055A patent/AU2022338055A1/en active Pending
- 2022-08-29 MX MX2024002567A patent/MX2024002567A/es unknown
- 2022-08-29 EP EP22777104.5A patent/EP4395821A1/en active Pending
- 2022-08-30 TW TW111132756A patent/TW202328178A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024112859A5 (https=) | ||
| JP7241058B2 (ja) | 抗Ｎ３ｐＧｌｕアミロイドベータペプチド抗体およびその使用 | |
| Relkin | Clinical trials of intravenous immunoglobulin for Alzheimer’s disease | |
| JP6190368B2 (ja) | 免疫グロブリンおよびｃ１−阻害剤を用いる組合せ療法 | |
| JP2021532126A5 (https=) | ||
| JP2020512368A (ja) | シヌクレイノパチーを治療するための組成物及び方法 | |
| JP2024532438A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| JP2023527542A5 (https=) | ||
| US20240148782A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| JP2024540226A5 (https=) | ||
| US20220127346A1 (en) | Methods of Safe Administration of Anti-Tau Antibody | |
| WO2024054416A1 (en) | Scyllo-inositol in combination with immunotherapeutics for the treatment of alzheimer's disease | |
| JP7781519B2 (ja) | グルカゴン受容体シグナル伝達に干渉することによって尿素サイクル異常症を治療する方法 | |
| EP3137097A1 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| US20240158486A1 (en) | ANTI-N3pGlu AMYLOID BETA ANTIBODIES AND USES THEREOF | |
| IL312380A (en) | Compounds and methods targeting interleukin-34 | |
| JP2024517796A (ja) | 抗ｂａｆｆｒ抗体を使用するループス腎炎の治療 | |
| RU2024108124A (ru) | Составы на основе антител к протофибриллам a-бета для подкожного введения и способы их применения | |
| JP2024517087A5 (https=) | ||
| CA3014669A1 (en) | Combination therapy | |
| WO2018158741A1 (en) | Psoriasis disease modification following long-term treatment with an il-17 antagonist | |
| WO2016189491A1 (en) | Novel formulation | |
| RU2025139087A (ru) | Способы лечения с применением антитела к протофибриллам белка а-бета | |
| WO2022234439A1 (en) | Treatment for systemic lupus erythematosus using anti-baffr antibodies |